Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure
Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter
Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter
View: Text | PDF
Research Article Cardiology

Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure

  • Text
  • PDF
Abstract

Widespread changes in cardiac gene expression occur during heart failure, yet the mechanisms responsible for coordinating these changes remain poorly understood. The Mediator complex represents a nodal point for modulating transcription by bridging chromatin-bound transcription factors with RNA polymerase II activity; it is reversibly regulated by its cyclin-dependent kinase 8 (Cdk8) kinase submodule. Here, we identified increased Cdk8 protein expression in human failing heart explants and determined the consequence of this increase in cardiac-specific Cdk8-expressing mice. Transgenic Cdk8 overexpression resulted in progressive dilated cardiomyopathy, heart failure, and premature lethality. Prior to functional decline, left ventricular cardiomyocytes were dramatically elongated, with disorganized transverse tubules and dysfunctional calcium handling. RNA sequencing results showed that myofilament gene isoforms not typically expressed in adult cardiomyocytes were enriched, while oxidative phosphorylation and fatty acid biosynthesis genes were downregulated. Interestingly, candidate upstream transcription factor expression levels and MAPK signaling pathways thought to determine cardiomyocyte size remained relatively unaffected, suggesting that Cdk8 functions within a novel growth regulatory pathway. Our findings show that manipulating cardiac gene expression through increased Cdk8 levels is detrimental to the heart by establishing a transcriptional program that induces pathological remodeling and eccentric hypertrophy culminating in heart failure.

Authors

Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter

×

Figure 1

Assessing the relevance of elevated Cdk8 expression in human dilated cardiomyopathy explants with constitutive cardiac overexpressing mice results in premature lethality.

Options: View larger image (or click on image) Download as PowerPoint
Assessing the relevance of elevated Cdk8 expression in human dilated car...
(A and B) Immunoblots (A) and summary data (B) of human dilated cardiomyopathy (DCM) and nonfailing control (NFC) left ventricular explant lysates. Cdk8, but not Med12, RNA Pol-II, or Gapdh, levels are significantly elevated in DCM lysates after normalization to total protein (Coomassie). *P < 0.01, 2-way ANOVA with Sidak’s multiple comparisons test, n = 3. (C) Schematic of Flag-tagged Cdk8 construct used for generating transgenic mice. Cdk8 is regulated by the Myh6 promoter and human GH1 poly-A terminator (hGH pA). (D) Example immunoblots of Cdk8 protein levels in ventricular lysates from WT hearts harvested at E18 through P1, P3, and P21, relative to P21 ventricular lysates from two independent Cdk8-transgenic lines, Tg8a and Tg8b. Each lane represents lysates from 2–3 pooled hearts at E18, P1, and P3 and 1 heart at P21. (E) Cdk8 protein expression summary data showing significant upregulation of Cdk8 at P21 in WT ventricles and significant overexpression at P21 in both Tg8a and Tg8b ventricles. *P < 0.05, 1-way ANOVA with Dunnett’s multiple comparisons test (vs. WT P21), n = 3–7 from 1–3 experiments. (F) Kaplan-Meier survival curves of male (M) and female (F) Cdk8-transgenic versus WT littermate mice from Tg8a and Tg8b lines. P < 0.0001, log-rank Mantel-Cox test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts